Projects funded by the NCN
Evaluation of the activity of MDM2-p53 antagonist RG7388 in mouse cancer models, alone and in combination with anti-PD-1/PD-L1 immunotherapy
2019/35/N/NZ5/03991
Keywords:
RG7388 p53 MDM2 cancer combination therapy cancer immunotherapy
Descriptors:
- NZ5_008:
- NZ5_007:
- NZ3_003:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 18 - announced on 2019-09-16
Amount awarded: 209 532 PLN
Project start date (Y-m-d): 2020-06-26
Project end date (Y-m-d): 2024-06-25
Project duration:: 48 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.